The 2026 cohort includes 28 early-career scientists based in the United States who are changing the world with their work.

Over 100 peptide-based drugs are currently available in the US, where they’re used to treat conditions ranging from type-2 diabetes to MS

Spotlight on the recipients of the award

Professor Emeritus John McDonald wrote the book for friends who were diagnosed and asked him about his unique perspective on the latest treatments.

Origin-of-life chemists from Scripps Research and the Georgia Institute of Technology propose that glyoxylate could have been the original source of sugars on the “prebiotic” Earth.

Five Georgia Tech College of Sciences researchers have been awarded CAREER grants from the National Science Foundation (NSF).

Early stage company from M.G. Finn lab developing drug delivery system for sustained, extended release that can vary from days to weeks

A look inside STEM Gems, an all-girls summer camp

In a new study, Georgia Tech researchers investigated whether 25 rare gene variants known to be associated with inflammatory bowel disease (IBD) play a role in risk for African Americans.

Georgia Tech researchers have uncovered eco-friendly bacterial proteins that stabilize methane clathrates, offering a green solution to climate challenges and potential implications for astrobiology.